JOVACLOST T CLOSTRIDIOSIS VACCINE
CLOSTRIDIUM PERFRINGENS (TYPES A, B, C AND D),
What it does
Clostridium is a type of bacteria that can be involved in certain medical treatments, particularly for infections.
Commonly used for: infections caused by Clostridium bacteria, Clostridium difficile infection (CDI)
Read more in plain English ↓Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.
Ask about this medicine
Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.
Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.
Source this medicineRegistration & product details
Source: Pharmacy and Poisons Board · fetched 2026-01-28 19:46:20 · updated 2026-08-03 02:55:24
About clostridium
Clostridium is a type of bacteria that can be involved in certain medical treatments, particularly for infections.
What it treats
- infections caused by Clostridium bacteria
- Clostridium difficile infection (CDI)
How it works
Clostridium-based treatments can help restore the balance of healthy bacteria in the gut, especially after antibiotic use.
Who it's for
This treatment is usually for individuals with specific bacterial infections, particularly those affecting the digestive system.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
About perfringens
Perfringens is not commonly used as a medicine, but it is a type of bacteria that can cause infections.
What it treats
- infections caused by Clostridium perfringens
How it works
Perfringens bacteria can produce toxins that damage tissues and cause illness.
Who it's for
Individuals with infections related to Clostridium perfringens.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
Clinical monograph: clostridium
Clostridium refers to a genus of bacteria known for its ability to form spores and produce toxins. Species such as Clostridium botulinum, Clostridium tetani, and Clostridium difficile are of particular clinical significance due to their role in various diseases. Clostridium infections can lead to conditions such as botulism, tetanus, and antibiotic-associated colitis, which can be severe and require urgent medical attention.
Indications
- Botulism
- Tetanus
- Clostridium difficile infection
- Pseudomembranous colitis
Dosage
Adults: Refer to specific clinical guidelines for dosage based on the condition being treated, as Clostridium infections require targeted therapies and may involve antitoxins, antibiotics, or supportive
Mechanism of action
Clostridium species produce potent exotoxins that interfere with normal cellular functions. For instance, Clostridium botulinum produces botulinum toxin, which inhibits acetylcholine release at the neuromuscular junction, leading to paralysis. Clostridium tetani produces tetanospasmin, which blocks inhibitory neurotransmitter release in the central nervous system, resulting in muscle spasms. Clostridium difficile releases toxins A and B, which disrupt the intestinal epithelium and cause inflammation, leading to diarrhea.
Pharmacodynamics
The pharmacodynamic effects of Clostridium toxins are primarily driven by their enzymatic activities. Botulinum toxin is the most potent toxin known and acts at neuromuscular junctions, causing flaccid paralysis. Tetanospasmin affects central nervous system neurotransmission, leading to spastic paralysis. Toxins produced by Clostridium difficile lead to cell death and inflammatory responses in the colon, contributing to pseudomembranous colitis.
Pharmacokinetics
The pharmacokinetics of Clostridium infections vary by species and toxin type. Generally, the toxins are absorbed into circulation following local release at infection sites. For example, botulinum toxin is absorbed through the gastrointestinal tract when ingested and distributed throughout the body, while tetanospasmin acts locally and is transported retrograde along motor neurons to the central nervous system. The duration of action is influenced by the toxin's ability to bind to receptors and enter cells, as well as the body's capacity for toxin clearance.
Pregnancy
The safety of clostridium species during pregnancy has not been established. Caution is advised when administering to pregnant individuals.
Breast-feeding
The effects of clostridium species during breastfeeding are not well studied. Caution is recommended.
Storage
Store in a cool, dry place away from direct sunlight. Specific storage conditions may vary based on formulation.
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.
Clinical monograph: perfringens
Perfringens is a term commonly associated with Clostridium perfringens, a bacterium known to cause various infections, including gas gangrene and food poisoning. The organism produces a range of toxins that can lead to tissue necrosis and systemic illness. Treatment often involves the use of antibiotics and surgical intervention to remove necrotic tissue.
Indications
- Gas gangrene
- Clostridial myonecrosis
- Food poisoning
- Soft tissue infections
Dosage
Children: Refer to specific antibiotic guidelines for dosing as it varies by drug choice and severity of the infection.
Adults: Refer to specific antibiotic guidelines for dosing as it varies by drug choice and severity of the infection.
Mechanism of action
Clostridium perfringens produces several toxins, including alpha-toxin (lecithinase), which disrupts cell membranes and promotes tissue destruction. The toxins act on phospholipids in cell membranes, leading to cell lysis and necrosis. Additionally, the bacterium's ability to produce gas (hydrogen and carbon dioxide) contributes to tissue swelling and further compromises blood flow.
Pharmacodynamics
The pharmacodynamics of antibiotics used against Clostridium perfringens involve the inhibition of bacterial cell wall synthesis (for beta-lactams), disruption of protein synthesis (for aminoglycosides and tetracyclines), or interference with nucleic acid synthesis (for fluoroquinolones). The effectiveness of these antibiotics can vary based on the specific strain and its susceptibility profile.
Pharmacokinetics
Pharmacokinetic properties depend on the specific antibiotic used to treat Clostridium perfringens infections. Generally, antibiotics may have varying absorption rates, distribution volumes, half-lives, and elimination routes, which can influence their dosing and effectiveness in treating infections caused by this organism.
Pregnancy
Perfringens is not typically used as a medication but is related to Clostridium perfringens, which is associated with foodborne illness. Consult healthcare providers for guidance during pregnancy.
Breast-feeding
Due to the lack of specific medicinal use, consult healthcare providers for advice regarding breastfeeding.
Storage
Store in a cool, dry place away from direct sunlight. If used in a laboratory context, follow specific biosafety guidelines.
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.
This drug in other countries
The same active ingredient registered across other registries we cover - including different brands.
- BLANTHRAX VACCINE · Prondil S.a
- Coglavax vaccine · Ceva–Phylaxia
- Covexin 10 Vaccine · Intervet South Africa
- Glanvac 3 Vaccine · Zoetis Australia Research And Manufacturing PTY Ltd
- Haemorrhagic Septicemia and Black quarter vaccine Inactivated · Biomed
- Litterguard · Zoetis